About us

AC International Medical – Reshaping a Healthy Future with Regenerative Medicine

Since its establishment, AC International Medical has been deeply engaged in the field of regenerative medicine, with the core mission of "driving precise treatment through innovative technology and safeguarding life potential with safety standards". After 18 years of development, it has become a professional platform connecting global patients with top-tier Japanese regenerative medicine resources, providing customized health solutions to over 30,000 international patients.

I. Core Strengths: 18 Years of Dedication, Setting Industry Benchmarks

1. Technological Foundation: Backed by World-Class Research Teams

AC International Medical’s R&D capabilities stem from its in-depth collaboration with Japan’s regenerative medicine sector, with its core team led by experts from top institutions such as Kyoto University and Kyoto Prefectural University of Medicine:


  • KAWAMOTO HIROSHI: Honorary Director of AC Japan Cell Laboratory, Director of Kyoto University Institute for Regenerative Medicine, MD. His leading "Killer T-Cell" technology is hailed as a "milestone that rewrites the history of cancer treatment", and his T-cell therapy for COVID-19 has been listed by the World Health Organization (WHO) as one of the "Top 10 Breakthrough Medical Technologies of the Future";

 

  • EAIBAI MATSUKAWA: Head of AC Japan Cell Laboratory, Professor at Osaka Public University, MD, and Top Consultant in Japan’s cell field, focusing on cell preparation and clinical translation research;

      • MATSUDA OSAMU: Immunology Expert at AC Japan Cell Laboratory, Professor of Immunology at Kyoto Prefectural University of Medicine, MD, specializing in the research of immunocell therapy mechanisms;

       

      • Kiuchi Shunichirou: Special Consultant of AC, Clinical Professor at Kyoto University School of Medicine, and Specialist in Japan’s Emergency Medicine field. With decades of clinical experience, he ensures the safety of treatment plans.

      Meanwhile, relying on the Kyoto University Institute for Regenerative Medicine (with 19 Nobel laureates and leading the formulation of international regenerative medicine standards) and the Kyoto Prefectural University of Medicine team, AC realizes the seamless connection of "research-clinical-translation", ensuring its technology aligns with the international cutting edge.

      Fig.: Core research team of Kyoto University Institute for Regenerative Medicine, which has produced 19 Nobel laureates and leads the formulation of global regenerative medicine technology standards

      Fig.: Kyoto Prefectural University of Medicine team cooperating with AC. Professor Matsuda Osamu (AC Immunology Expert) is a core member of this team, focusing on immunocell therapy research

      2. Safety & Compliance: Safeguarding the Entire Treatment Process with the Highest Standards

      As a model of compliance in Japan’s regenerative medicine sector, AC International Medical strictly adheres to the Act on Ensuring the Safety of Regenerative Medicine, under the full supervision of Japan’s Ministry of Health, Labour and Welfare and relevant regulatory authorities. Its core safety advantages include:

      • Qualifications & Certifications: Holding 11 "Regenerative Medicine Implementation Program Certifications", along with specialized permits for blood purification, cell processing and production, and qualification as an Osaka Emergency Specialist Clinic, covering the entire business chain of regenerative medicine;

       

      • Quality Control: Both cell preparation and treatment environments meet the highest cleanliness standards of GMP (Good Manufacturing Practice). Visualized operation rooms monitor quality in real time, with traceable standardized processes for every step from cell collection and cryopreservation to clinical treatment;

       

      • Efficacy Verification: The independently developed cell preparation system achieves a cell survival rate of over 95%. Follow-up data over the past 5 years shows that the effective improvement rate of autologous stem cell therapy reaches 91.2%, with service quality and professional technology ranking among the industry’s top tier.

      Fig1: Core qualification certificates held by AC International Medical, including Class II/III Regenerative Medicine Permits and Specialized Blood Purification Permits, all issued by Japan’s Ministry of Health, Labour and Welfare and authoritative institutions

      Fig2: GMP-level clean operation room at AC’s cell preparation center, equipped with high-temperature sterilization equipment to ensure sterility and controllability of the cell preparation process

      II. Service Features: Internationalization + Personalization, Breaking Cross-Border Medical Barriers

      1. Customized Treatment: One Plan per Patient, Precisely Matching Needs

      Deeply understanding that each patient has unique health conditions and needs, AC has established a service system of "full-cycle assessment – customized plan – post-treatment follow-up":

      • Based on the patient’s age, health history, test reports, and other information, AC collaborates with Japanese expert teams to develop exclusive treatment plans, avoiding "one-size-fits-all" medical care;
      • Covering the entire scenario of "daily maintenance – disease treatment – anti-aging repair", from daily maintenance programs such as NMN Infusion and Hermes Infusion to treatment programs like autologous adipose stem cells (for diabetes, liver function repair, cranial nerve repair, etc.), autologous NK immune cells (for cancer cell clearance, chronic inflammation reduction), and blood purification (for cardiovascular disease prevention), all can precisely match patient needs.

      Fig.: Activated NK immune cells (ID: AC037-NK) independently developed by AC, which can directly clear cancer cells and virus-infected cells without immune rejection risk

      2. International Experience: Multilingual Support, Balancing Privacy and Comfort

      To eliminate communication and experience barriers in cross-border medical care, AC has built an exclusive service system:

      • Multilingual Communication: Equipped with multilingual medical translators (including Chinese and English) and international patient coordinators, ensuring no communication barriers throughout consultation, appointment, and treatment;
      • Privacy-Protected Environment: Independent consultation rooms and rehabilitation rest areas are set up to create a stress-relieving medical environment and protect patient privacy;
      • Full-Process Assistance: Providing one-stop services such as visa assistance, transportation and accommodation recommendations, and post-treatment follow-up, allowing patients to focus on treatment and rehabilitation.

      Fig.: Independent consultation rooms and rehabilitation rest areas at AC International Medical, focusing on patient privacy protection and medical comfort, providing a stress-relieving treatment experience

      III. Vision: Continuous Upgrading, Making Regenerative Medicine Accessible to More People

      In February 2025, AC International Medical launched a brand upgrade to further integrate Japanese regenerative medicine resources, optimize treatment plans and service processes, and aim to bring "safe, precise, and efficient" regenerative medicine services to more people in need.

      In the future, we will continue to deepen technological innovation and service optimization, with the goal of "reactivating life potential and reshaping a healthy future", and become a trusted regenerative medicine partner for global patients.


      Fig.: Visual logo of AC International Medical’s 2025 brand upgrade, symbolizing the comprehensive iteration of technology and services

      Authoritative Endorsements: Industry Recognition, Proving Strength

      • Member Unit of the Japanese Society for Regenerative Medicine
      • Certified Institution of the Japan Blood Purification Association
      • Cooperation Unit of the Japan Anti-Aging Association
      • Compliant Medical Institution of the Japan Medical Association



      Fig.: Industry authoritative endorsements obtained by AC International Medical, including certifications from the Japanese Society for Regenerative Medicine and the Japan Blood Purification Association